BSX Boston Scientific Corp

$103.03

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Updated On 8/18/2025

About Boston Scientific Corp

Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.

Website: https://www.bostonscientific.com

Sector
LIFE SCIENCES
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
885725
Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA, US
Valuation
Market Cap
$140.69B
P/E Ratio
76.10
PEG Ratio
1.87
Price to Book
6.46
Performance
EPS
$1.25
Dividend Yield
Profit Margin
11.10%
ROE
8.89%
Technicals
50D MA
$100.16
200D MA
$89.39
52W High
$107.17
52W Low
$66.80
Fundamentals
Shares Outstanding
1B
Target Price
$114.94
Beta
0.73

BSX EPS Estimates vs Actual

Estimated
Actual

BSX News & Sentiment

Aug 18, 2025 • Benzinga SOMEWHAT-BULLISH
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years - Boston Scientific ( NYSE:BSX )
Boston Scientific BSX has outperformed the market over the past 10 years by 7.53% on an annualized basis producing an average annual return of 20.65%. Currently, Boston Scientific has a market capitalization of $152.86 billion.
Aug 18, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Brokers Suggest Investing in Boston Scientific ( BSX ) : Read This Before Placing a Bet
Based on the average brokerage recommendation (ABR), Boston Scientific (BSX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Aug 14, 2025 • Motley Fool SOMEWHAT-BULLISH
Elutia ( ELUT ) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.Thursday, Aug. 14, 2025 at 5 p.m. ETChief Executive Officer - Randy MillsContinue reading ...
Aug 14, 2025 • Motley Fool SOMEWHAT-BULLISH
Elutia Posts Narrower Loss in Fiscal Q2
Elutia ( NASDAQ:ELUT ) , a medical technology company specializing in biologic products for device protection and surgical reconstruction, released its second-quarter earnings on August 14, 2025, reporting results for the period ended June 30.
Aug 14, 2025 • Zacks Commentary NEUTRAL
Accuray Stock Down as Q4 Earnings Miss Estimates, Revenues Down Y/Y
ARAY stock down after Q4 earnings miss estimates, with product sales hit by tariffs and regional demand softness.
Aug 14, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
HQY's HSA growth, AI-driven efficiencies, and strong Q1 results fuel optimism despite data security concerns.
Sentiment Snapshot

Average Sentiment Score:

0.161
50 articles with scored sentiment

Overall Sentiment:

Bullish

BSX Reported Earnings

Apr 22, 2025
Mar 31, 2025 (Pre market)
0.08 Surprise
  • Reported EPS: $0.75
  • Estimate: $0.67
  • Whisper:
  • Surprise %: 11.5%
Jan 29, 2025
Dec 31, 2024 (Pre market)
0.04 Surprise
  • Reported EPS: $0.70
  • Estimate: $0.66
  • Whisper:
  • Surprise %: 6.6%
Oct 23, 2024
Sep 30, 2024 (Pre market)
0.04 Surprise
  • Reported EPS: $0.63
  • Estimate: $0.59
  • Whisper:
  • Surprise %: 6.8%
Jul 24, 2024
Jun 30, 2024 (Pre market)
0.04 Surprise
  • Reported EPS: $0.62
  • Estimate: $0.58
  • Whisper:
  • Surprise %: 6.9%
Apr 24, 2024
Mar 31, 2024 (Pre market)
0.05 Surprise
  • Reported EPS: $0.56
  • Estimate: $0.51
  • Whisper:
  • Surprise %: 9.8%
Jan 31, 2024
Dec 31, 2023 (Pre market)
0.04 Surprise
  • Reported EPS: $0.55
  • Estimate: $0.51
  • Whisper:
  • Surprise %: 7.8%
Oct 26, 2023
Sep 30, 2023 (Pre market)
0.02 Surprise
  • Reported EPS: $0.50
  • Estimate: $0.48
  • Whisper:
  • Surprise %: 4.2%
Jul 27, 2023
Jun 30, 2023 (Pre market)
0.04 Surprise
  • Reported EPS: $0.53
  • Estimate: $0.49
  • Whisper:
  • Surprise %: 8.2%
Apr 26, 2023
Mar 31, 2023 (Pre market)
0.03 Surprise
  • Reported EPS: $0.47
  • Estimate: $0.44
  • Whisper:
  • Surprise %: 6.8%

Financials